Pancreatic Cancer Research

ResearcherThe University of Texas at San Antonio Health Science CenterNo recent work listed

Amanda R. Muñoz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8534-5037; OpenAlex author ID A5033518752. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 1 paper

Papers 4

  1. Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. First author DOI 10.1016/j.canlet.2018.01.057↗
  2. Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells. First author DOI 10.1002/mc.22503↗
  3. Pancreatic cancer: Current status and Challenges. Co-author DOI 10.1007/s40495-017-0112-3↗
  4. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth. First author DOI 10.18632/oncotarget.1810↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Addanki Pratap Kumar · 4 shared papers, 2014–2018 · strength 0.29
  2. Rita Ghosh · 4 shared papers, 2014–2018 · strength 0.29
  3. Divya Chakravarthy · 2 shared papers, 2017–2018 · strength 0.16
  4. Jingjing Gong · 2 shared papers, 2014–2017 · strength 0.13
  5. Rosa F. Hwang · 1 shared paper, 2018 · strength 0.08
  6. James W. Freeman · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.